Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Gefitinib in Locally Advanced Esophageal Cancer
NCT00100945Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma, sponsored by Cancer and Leukemia Group B. Started Jul 2005; status: completed.
02
Drugs
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00100945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100945.